Effects of Anthocyans on Cardiovascular and Sympathetic Function
NCT00634387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2011-07-06
Summary
Anthocyans modify cardiovascular and sympathetic function
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Anthocyans
Anthocyans
- OTHER
-
placebo
- DIETARY_SUPPLEMENT
-
Anthocyans
Sponsors & Collaborators
-
MedPalett
collaborator UNKNOWN -
Ullevaal University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 35 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2009-06-30
- Completion
- 2009-06-30
Countries
- Norway
Study Locations
More Related Trials
-
Conditioned Pharmacotherapeutic Effects in Hypertension
NCT02056626 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Effects of Norepinephrine
NCT05761522 ·Status: RECRUITING
-
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation
NCT00604331 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
NCT02391142 ·Status: UNKNOWN ·Phase: NA
-
Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
NCT05728632 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
NCT05168462 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation
NCT01157572 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of the Autonomic Nervous System in Response to Exercise in Hypertensive Individuals
NCT04371757 ·Status: UNKNOWN ·Phase: NA
-
Effects of Labetalol on Nicotine Administration in Humans - 14
NCT00000297 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiovascular Effects of Selective I(f)-Channel Blockade
NCT00865917 ·Status: UNKNOWN ·Phase: PHASE2
-
Targeting Sympathetic Overactivity in Heart Failure Patients With Statins
NCT01097785 ·Status: COMPLETED ·Phase: NA
-
Upregulating the Nitric Oxide Pathway To Restore Autonomic Phenotype (UNTRAP).
NCT03658174 ·Status: COMPLETED ·Phase: NA
-
POTS Adrenergic Ab (CIHR Aims #1&2)
NCT02673996 ·Status: RECRUITING
-
Anxiety and Cardiovascular Autonomic Control
NCT00005471 ·Status: COMPLETED
-
A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients
NCT00200460 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
NCT04826497 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock
NCT04964492 ·Status: UNKNOWN
-
Dysautonomia in Patients Post COVID-19 Infection
NCT04716465 ·Status: UNKNOWN
-
Mechanisms of Refractory Hypertension (Carvedilol)
NCT02357004 ·Status: WITHDRAWN ·Phase: NA
-
Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit
NCT06121115 ·Status: COMPLETED
-
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
NCT06864234 ·Status: RECRUITING ·Phase: PHASE4
-
Pathophysiology of Orthostatic Intolerance
NCT00608725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation
NCT02315313 ·Status: UNKNOWN
-
The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome
NCT01761825 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
NCT01202175 ·Status: COMPLETED ·Phase: PHASE4